BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17987251)

  • 21. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible association of nicastrin polymorphisms and Alzheimer disease in the Finnish population.
    Helisalmi S; Dermaut B; Hiltunen M; Mannermaa A; Van den Broeck M; Lehtovirta M; Koivisto AM; Iivonen S; Cruts M; Soininen H; Van Broeckhoven C
    Neurology; 2004 Jul; 63(1):173-5. PubMed ID: 15249634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males.
    Reynolds WF; Hiltunen M; Pirskanen M; Mannermaa A; Helisalmi S; Lehtovirta M; Alafuzoff I; Soininen H
    Neurology; 2000 Nov; 55(9):1284-90. PubMed ID: 11087769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
    Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
    Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
    Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
    J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
    Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females.
    Porrello E; Monti MC; Sinforiani E; Cairati M; Guaita A; Montomoli C; Govoni S; Racchi M
    Eur J Neurol; 2006 Jun; 13(6):639-44. PubMed ID: 16796589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
    Helisalmi S; Tarvainen T; Vepsäläinen S; Koivisto AM; Hiltunen M; Soininen H
    Neurosci Lett; 2008 Aug; 441(2):233-6. PubMed ID: 18573313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
    Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
    Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.
    Martin ER; Lai EH; Gilbert JR; Rogala AR; Afshari AJ; Riley J; Finch KL; Stevens JF; Livak KJ; Slotterbeck BD; Slifer SH; Warren LL; Conneally PM; Schmechel DE; Purvis I; Pericak-Vance MA; Roses AD; Vance JM
    Am J Hum Genet; 2000 Aug; 67(2):383-94. PubMed ID: 10869235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.
    Saarela MS; Lehtimäki T; Rinne JO; Hervonen A; Jylhä M; Röyttä M; Ahonen JP; Mattila KM
    Neurosci Lett; 2004 Sep; 367(3):336-9. PubMed ID: 15337261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
    Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
    Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A loss of function variant in CASP7 protects against Alzheimer's disease in homozygous APOE ε4 allele carriers.
    Ayers KL; Mirshahi UL; Wardeh AH; Murray MF; Hao K; Glicksberg BS; Li S; Carey DJ; Chen R
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):445. PubMed ID: 27358062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
    Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.
    Laws SM; Perneczky R; Wagenpfeil S; Müller U; Förstl H; Martins RN; Kurz A; Riemenschneider M
    Hum Mutat; 2005 Jul; 26(1):29-35. PubMed ID: 15895461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.
    Licastro F; Pedrini S; Govoni M; Pession A; Ferri C; Annoni G; Casadei V; Veglia F; Bertolini S; Grimaldi LM
    Neurosci Lett; 1999 Aug; 270(3):129-32. PubMed ID: 10462111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.